fbpx
QQQ
-2.49
316.84
-0.79%
DIA
-2.00
312.11
-0.64%
SPY
-2.91
381.49
-0.77%
TLT
+ 0.60
150.62
+ 0.4%
GLD
-2.07
175.30
-1.19%

Cresco Labs Reports Q2 Earnings: 'We Delivered An Outstanding Quarter'

August 22, 2019 9:34 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Cresco Labs Reports Q2 Earnings: 'We Delivered An Outstanding Quarter'

Cresco Labs Inc. (CSE:CL) (OTC:CRLBF) reported its unaudited financial results for the second quarter. Highlights from the report include its revenue being up 253% year-over-year or reaching $29.9 million, which the company attributed to its expansion into new markets and its growth in the states it already operates.

The company’s second-quarter adjusted EBITDA reached $14.5 million, versus $4.8 million in the same period last year.

Cresco Labs disclosed a net loss of $3.9 million for the quarter, compared to a net income of $1.6 million in the same quarter last year.

Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.

“We delivered an outstanding quarter that reflects the leading positions we have established in some of the most attractive markets in the cannabis industry,” CEO Charlie Bachtell said in a statement. “While our increasing profitability demonstrates our ability to effectively execute and leverage the attractive model we have developed, we continue to operate with a long-term perspective and make investments to position Cresco Labs to lead the cannabis industry in the years to come."

Cresco Labs traded around $8.36 per share at time of publication.

Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter.


Related Articles

Cantor Analyst Raises Aphria And Tilray Price Targets Amid Merger

Cantor Fitzgerald analyst Pablo Zuanic expressed disappointment by Aphria Inc. (TSX: APHA) (NASDAQ: APHA) quarterly results in an analyst note published Friday. read more

Aphria Posts Higher Revenue, Plans To Close Tilray Deal In Q2

Aphria Inc. (TSX: APHA) (NASDAQ: APHA) posted net cannabis revenue of CA$67.9 million for the second quarter of 2021 — 99% higher than in the prior-year quarter. Overall, net revenue hovered CA$160.5 million ($126.6 million). That's up by 33% from the same period in fiscal 2020. read more

Aphria Q2 Adj. EPS C$0.01, Up From C$(0.19) YoY Net Revenue C$160.5M, Up 33% YoY

Earnings Roundup: Next Green, Namaste, Item 9, Indiva

Next Green Reports Q4 Results And Corporate Appointments read more

Earnings Update: Organigram, Grow Generation, KushCo

Organigram Plans To Ramp Up Staff Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) posted financial results for the first quarter of fiscal 2021. read more